Patient | Age | Sex | PTV-initial volume[cm3] | PTV-boost volume[cm3] | Tumor site | TNM* |
---|---|---|---|---|---|---|
1 | 45 | Male | 674.20 | 64.82 | Ra | T3N2M0 |
2 | 47 | Male | 835.88 | 314.1 | RS | T4N2M0 |
3 | 45 | Male | 737.86 | 198.49 | Rb | T4N0M0 |
4 | 69 | Male | 960.23 | 498.86 | Ra-Rb | T3N3M0 |
5 | 66 | Male | 1157.58 | 149.31 | Rb | T3N3M0 |
6 | 43 | Male | 1082.17 | 309.49 | Rb | T4N3M0 |
7 | 32 | Male | 1368.73 | 400.46 | RS | T4N2M0 |
8 | 60 | Male | 909.71 | 475.31 | Ra-Rb | T4N1M0 |
9 | 45 | Male | 834.62 | 241.53 | Rb | T3N3M0 |
10 | 66 | Male | 1055.13 | 224.14 | Rb | T3N3M0 |
11 | 47 | Male | 1252.46 | 371.59 | RS-Ra | T3N3M0 |
12 | 80 | Male | 884.12 | 249.85 | Rb | T3N3M1 |
13 | 40 | Male | 1011.44 | 265.38 | Rb | T3N1M0 |
14 | 63 | Male | 636.49 | 171.02 | Rb | T3N0M0 |
15 | 58 | Male | 1133.94 | 242.09 | Rb | T2N0M0 |
16 | 53 | Male | 1110.99 | 285.41 | RS | T3N0M0 |
17 | 70 | Male | 1120.22 | 143.99 | RS-Ra | T4N0M0 |
18 | 59 | Male | 976.78 | 295.41 | Rb | T3N1M0 |
19 | 71 | Male | 759.86 | 225.12 | Rb | T3N0M0 |
20 | 50 | Female | 676.39 | 219.22 | Rb | T3N0M0 |
21 | 63 | Female | 724.30 | 242.85 | Rb | T3N0M0 |
22 | 58 | Female | 1039.00 | 289.04 | Rb | T4N1M1 |
23 | 52 | Male | 895.36 | 255.85 | Ra-Rb | T3N2M0 |
24 | 77 | Male | 888.98 | 285.63 | Ra-Rb | T3N0M0 |
25 | 55 | Male | 824.67 | 249.67 | Rb | T3N1M0 |
26 | 67 | Female | 980.13 | 237.07 | Ra-Rb | T4N1M1 |